ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 321 filers reported holding ISIS PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 1.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $19,273,000 | +552.7% | 476,814 | +829.2% | 0.05% | +557.1% |
| Q2 2015 | $2,953,000 | -50.1% | 51,314 | -62.5% | 0.01% | -50.0% |
| Q1 2014 | $5,916,000 | -54.5% | 136,914 | -58.0% | 0.01% | -54.8% |
| Q4 2013 | $12,992,000 | +5.2% | 326,114 | -0.9% | 0.03% | +3.3% |
| Q3 2013 | $12,347,000 | +1546.3% | 328,914 | +1078.3% | 0.03% | +1400.0% |
| Q2 2013 | $750,000 | – | 27,914 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 5,976,526 | $368,991,000 | 11.95% |
| HWG Holdings LP | 155,584 | $9,606,000 | 6.84% |
| DOWLING & YAHNKE LLC | 676,313 | $41,756,000 | 5.20% |
| Ghost Tree Capital, LLC | 150,000 | $9,261,000 | 4.44% |
| WILLIAM HARRIS INVESTORS INC | 276,870 | $17,094,000 | 4.41% |
| GRAYBILL WEALTH MANAGEMENT, LTD. | 61,225 | $3,780,000 | 2.87% |
| Opus Point Partners Management, LLC | 45,418 | $2,804,000 | 2.77% |
| PINNACLE ASSOCIATES LTD | 1,917,838 | $118,407,000 | 2.32% |
| Ghost Tree Capital, LLC | 50,000 | $3,087,000 | 1.48% |
| Adamant Biomedical Investments AG | 100,000 | $6,174,000 | 1.48% |